Junjian Liu | Vice President, Head of Biologics Discovery
Innovent Biologics, Inc | China

Junjian Liu, Vice President, Head of Biologics Discovery, Innovent Biologics, Inc

With nearly 20 years of in-depth experiences in biologics discovery and technology platforms, Dr. Liu is responsible for biologics discovery programs at Innovent. He is member of the following organizations: “Leadership in Innovation and Entrepreneurship of Jiangsu Province”, “Innovative and Entrepreneurship Talent in Suzhou (Major Innovative Team)”, and “Leading Scholars of SIP”. Prior to his current position, he was Executive Director of Biologics Discovery at Wuxi Biologics, Inc. developing technology platform for novel biologics and building early phase pipeline; Dr. Liu was also a group leader at Abbvie for leading pipeline projects in autoimmune diseases and oncology.

Appearances:



Phar-East Day One @ 16:00

Building the framework of combination immuno-oncology (I-O)

    style="font-size: 10.0pt;">
  •     Overview of current progress, lessons learnt and future prospect of combination I-O
  •     Investigating several combination of checkpoint inhibitors for more effective treatment
  •     Rational vs non rational combinations between checkpoint inhibitors and chemo/radio therapies, which works best?

back to speakers